123 related articles for article (PubMed ID: 38462863)
1. Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma.
Lin J; Xu N; An W
J Coll Physicians Surg Pak; 2024 Mar; 34(3):290-295. PubMed ID: 38462863
[TBL] [Abstract][Full Text] [Related]
2. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
Alatan H; Chen Y; Zhou J; Wang L
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
[TBL] [Abstract][Full Text] [Related]
5. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
8. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
9. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
10. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
[No Abstract] [Full Text] [Related]
11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
12. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy.
Zhang H; Huo J; Jiang W; Shan Q
Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
14. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
Yang G; Jian L; Lin X; Zhu A; Wen G
Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential hub genes of gastric cancer.
Zhou XD; Qu YW; Wang L; Jia FH; Chen P; Wang YP; Liu HF
Medicine (Baltimore); 2022 Oct; 101(41):e30741. PubMed ID: 36254003
[TBL] [Abstract][Full Text] [Related]
20. The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
Ding C; Zhang Q; Jiang X; Wei D; Xu S; Li Q; Wu M; Wang H
Comput Math Methods Med; 2022; 2022():4321466. PubMed ID: 35756405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]